Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Other Non-Current Assets: 2016-2025

Historic Other Non-Current Assets for Rhythm Pharmaceuticals (RYTM) over the last 8 years, with Sep 2025 value amounting to $671,000.

  • Rhythm Pharmaceuticals' Other Non-Current Assets rose 45.24% to $671,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $671,000, marking a year-over-year increase of 45.24%. This contributed to the annual value of $464,000 for FY2024, which is 41.46% up from last year.
  • Per Rhythm Pharmaceuticals' latest filing, its Other Non-Current Assets stood at $671,000 for Q3 2025, which was up 27.32% from $527,000 recorded in Q2 2025.
  • Rhythm Pharmaceuticals' 5-year Other Non-Current Assets high stood at $671,000 for Q3 2025, and its period low was $328,000 during Q1 2021.
  • Its 3-year average for Other Non-Current Assets is $438,182, with a median of $460,000 in 2024.
  • In the last 5 years, Rhythm Pharmaceuticals' Other Non-Current Assets dropped by 18.61% in 2021 and then surged by 45.24% in 2025.
  • Quarterly analysis of 5 years shows Rhythm Pharmaceuticals' Other Non-Current Assets stood at $328,000 in 2021, then remained steady at $328,000 in 2022, then remained steady at $328,000 in 2023, then soared by 41.46% to $464,000 in 2024, then skyrocketed by 45.24% to $671,000 in 2025.
  • Its Other Non-Current Assets stands at $671,000 for Q3 2025, versus $527,000 for Q2 2025 and $464,000 for Q1 2025.